[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@SnupSnus "@JialiangLiang @seedy19tron I am not saying that there's a "safety issue" w Rinvoq but it carries a (class) black box (a class too IRCC) CV-mortality label and all in all just compare the AE's -ENTYVIO might be the closest to pbo like safety in drug development we got so far-this is why it's King in IBD"
@SnupSnus on X 2025-07-26 04:35:15 UTC 1640 followers, XXX engagements

"@Andre_AGTC I like-correct me if I am wrong- how your portfolio is so focused on the lifeblood of the sector: the buyout Notably absent $CYTK and radiopharma- is that for specific reasons"
@SnupSnus on X 2025-07-24 00:57:02 UTC 1639 followers, XXX engagements

"Reduced $BBIO a bit (1/5 -now just shy of 20%) and added some $NAMS- the Alz data (remember: w.o. cognition or brain imaging) might be Meme moment. not sure tbh about Overall and CVOT prospects -even though I have been doing loads of reading-"
@SnupSnus on X 2025-07-25 15:25:23 UTC 1640 followers, XXX engagements